RankingsPricing
  1. JP-listed companies
  2. SanBio Company Limited
  3. Financials
  4. Operating income

SanBio Company Limited【JP:4592】

Market cap
¥122.2B
P/E ratio
-30.2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating income (Million JPY)YoY (%)
Jan 31, 2025-3,516-22.54%
Jan 31, 2024-4,539-42.54%
Jan 31, 2023-7,899+19.32%
Jan 31, 2022-6,620+14.12%
Jan 31, 2021-5,801+5.74%
Jan 31, 2020-5,486+46.93%
Jan 31, 2019-3,734-14.72%
Jan 31, 2018-4,378+126.60%
Jan 31, 2017-1,932+71.72%
Jan 31, 2016-1,125-150.04%
Jan 31, 20152,249

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)